CAS RN: 2639939-72-1
1,3-Dioxolo[4,5-e][1,3,2]dioxaphosphepin, 4,4,8,8-tetrakis(3,5-diethylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-, (3aS,8aS)-
Product Availability
Choose a grade to view its available package options.
5 package records3 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20250515 |
100mg |
In stock |
Shanghai, Tianjin, Wuhan, Chengdu | | Inquiry |
| Batchno.20250430 |
100mg / 250mg / 1g |
Out of stock |
| 8-10 business days | Inquiry |
| Batchno.20260105 |
1g |
In stock |
Shanghai, Tianjin, Wuhan, Chengdu | | Inquiry |
| Batchno.20260610 |
250mg |
In stock |
Shanghai, Shenzhen, Tianjin, Wuhan, Chengdu | | Inquiry |
| Batchno.20250220 |
5g |
Out of stock |
| | Inquiry |
-
Product code:
starshine_CAS2639939-72-1
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
2639939-72-1 / (3aS,8aS)-4,4,8,8-tetrakis(3,5-diethylphenyl)-2,2-dimethyl-6-phenyl-3a,8a-dihydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
Standard CAS: 2639939-72-1
Multi CAS: No
Basic Information
CAS
2639939-72-1
Multi CAS
No
Molecular Formula
C53H65O4P
Molecular Weight
797.100000
Exact Mass
796.462048
SMILES
CCC1=CC(=CC(=C1)C2([C@@H]3[C@@H](C(OP(O2)C4=CC=CC=C4)(C5=CC(=CC(=C5)CC)CC)C6=CC(=CC(=C6)CC)CC)OC(O3)(C)C)C7=CC(=CC(=C7)CC)CC)CC
InChI
InChI=1S/C53H65O4P/c1-11-36-24-37(12-2)29-44(28-36)52(45-30-38(13-3)25-39(14-4)31-45)49-50(55-51(9,10)54-49)53(46-32-40(15-5)26-41(16-6)33-46,47-34-42(17-7)27-43(18-8)35-47)57-58(56-52)48-22-20-19-21-23-48/h19-35,49-50H,11-18H2,1-10H3/t49-,50-/m0/s1
InChIKey
BNAMLZQDVVNLSE-WLTNIFSVSA-N
Computed Properties
Structural Parameters
Heavy atom count
58
Aromatic heavy atom count
30
Fraction Csp3
0.43
Rotatable bonds
13
H-bond acceptors
4
Molar refractivity
241.34
TPSA
36.92
LogP / Solubility
WLOGP
12.58
MLOGP
11.14
XLogP3
14.1
Consensus LogP
12.61
Log S (ESOL)
-12.23
Class (ESOL)
Insoluble
Log S (Ali)
-15.18
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-16.84
Class (SILICOS-IT)
Insoluble
ADME
GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
No
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
1.35
Drug-likeness / Medicinal Chemistry
Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
7